康缘药业(600557.SH)部分董高层拟合计增持不低于12万股公司股份

Core Viewpoint - Kangyuan Pharmaceutical (600557.SH) announced that several key executives plan to increase their holdings in the company, reflecting their confidence in its future development and long-term investment value [1] Group 1 - The company's general manager, Yang Yongchun, along with other board members and vice presidents, will collectively purchase no less than 120,000 shares [1] - The share buyback will be conducted through the Shanghai Stock Exchange trading system within one month from the announcement date [1] - The executives are using their own funds for this share purchase, indicating a strong belief in the company's potential [1]